1. Home
  2. CIG vs TLX Comparison

CIG vs TLX Comparison

Compare CIG & TLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CIG
  • TLX
  • Stock Information
  • Founded
  • CIG 1952
  • TLX 2015
  • Country
  • CIG Brazil
  • TLX Australia
  • Employees
  • CIG N/A
  • TLX N/A
  • Industry
  • CIG Electric Utilities: Central
  • TLX Biotechnology: Pharmaceutical Preparations
  • Sector
  • CIG Utilities
  • TLX Health Care
  • Exchange
  • CIG Nasdaq
  • TLX Nasdaq
  • Market Cap
  • CIG 5.5B
  • TLX 5.7B
  • IPO Year
  • CIG N/A
  • TLX N/A
  • Fundamental
  • Price
  • CIG $1.83
  • TLX $13.05
  • Analyst Decision
  • CIG
  • TLX Strong Buy
  • Analyst Count
  • CIG 0
  • TLX 3
  • Target Price
  • CIG N/A
  • TLX $22.33
  • AVG Volume (30 Days)
  • CIG 2.5M
  • TLX 58.9K
  • Earning Date
  • CIG 08-14-2025
  • TLX 01-01-0001
  • Dividend Yield
  • CIG 16.53%
  • TLX N/A
  • EPS Growth
  • CIG 26.89
  • TLX 798.14
  • EPS
  • CIG 0.43
  • TLX 0.09
  • Revenue
  • CIG $7,082,233,171.00
  • TLX $484,687,790.00
  • Revenue This Year
  • CIG N/A
  • TLX N/A
  • Revenue Next Year
  • CIG N/A
  • TLX N/A
  • P/E Ratio
  • CIG $4.98
  • TLX $142.43
  • Revenue Growth
  • CIG 8.98
  • TLX 55.85
  • 52 Week Low
  • CIG $1.59
  • TLX $12.90
  • 52 Week High
  • CIG $2.19
  • TLX $30.36
  • Technical
  • Relative Strength Index (RSI)
  • CIG 42.31
  • TLX N/A
  • Support Level
  • CIG $1.79
  • TLX N/A
  • Resistance Level
  • CIG $1.88
  • TLX N/A
  • Average True Range (ATR)
  • CIG 0.04
  • TLX 0.00
  • MACD
  • CIG -0.01
  • TLX 0.00
  • Stochastic Oscillator
  • CIG 31.82
  • TLX 0.00

About CIG Comp En De Mn Cemig ADS

Cia Energetica DE Minas Gerais - Cemig, formerly Energy Company of Minas Gerais, is a Brazilian power company that generates, transmits, and distributes electricity. As one of the power companies in Brazil, the firm operates across Brazilian states and Chile. The company has various subsidiaries and operates chiefly through its generation, transmission, distribution, and gas segments. The majority of the company's revenue is derived from electricity sales to consumers. The company generates power through hydroelectric resources and, secondarily, through thermal and wind resources.

About TLX Telix Pharmaceuticals Limited American Depositary Shares

Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.

Share on Social Networks: